Transcutaneous Bilirubinometers Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)

Transcutaneous Bilirubinometers Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)

The transcutaneous bilirubinometers market is expected to register a CAGR of 6% during the forecast period. Transcutaneous bilirubinometers are widely used for noninvasive transcutaneous bilirubin with hyperbilirubinemia.

• The market has been growing at a good rate, attributing to the rising incidence of jaundice in neonatal patients, and technological advancements in the transcutaneous bilirubinometers. As per the National Institute of Health (NIH), in 2019, neonatal hyperbilirubinemia was a leading cause of hospitalization, an estimate of 60-80% of newborn babies had been affected by this condition, which further results in driving the transcutaneous bilirubinometers for screening infants.
• Moreover, the technological advancements, coupled with the increasing demand for noninvasive and reliable techniques for the measurement of serum bilirubin, are also likely to propel the market to a certain extent. However, the high cost of bilirubin meters and a shortage of skilled workforce may hamper the market.

Portable transcutaneous billirubinometers are expected to witness a healthy growth rate in the future, attributing to its flexibility, ease of use, non- invasive, and increased mobility. As technological advancements in the transcutaneous billirubinometers increase, it may result in the high adoptions in diagnostic laboratories and hospitals for screening purposes. This high demand for portable transcutaneous billirubinometers results in promoting the segment growth.

North America is expected to hold a significant market share in the global transcutaneous bilirubinometers market, due to the increasing incidence of jaundice in neonatal patients, increasing healthcare expenditure, and the presence of well-established healthcare infrastructure. As per the Global Health Data Exchange, in 2017, the prevalence rates in United States for hemolytic diseases and neonatal jaundice had increased (27,736) from earlier years, resulting in the adoption of transcutaneous bilirubinometers for screening and diagnosis. This adoption of bilirubinometers has been leading to the growth of the market tsudied in this region.

Some of the companies that are currently dominating the market are Drägerwerk AG & Co. KGaA, Xuzhou Kejian Hi-tech Co. Ltd, Avihealthcare, Mennen Medical Ltd ( Nektop Ltd), Koninklijke Philips NV, Micro Lab Instruments, Zhengzhou Dison Instrument And Meter Co. Ltd, DAVID, and GINEVRI Srl, among others.

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support